Scott Morris leads the Health Sciences business at Change Healthcare, now part of Optum Insight following the recent completion of the company merger with Change. Scott oversees the Clinical Trials Access Network solution, a patient matching and provider referral solution designed to improve patient access to appropriate clinical trials. He is an experienced executive who has successfully introduced innovations and scaled new offerings in data, analytics, technology, and services that support life sciences and the broader health care industry. Before joining Change Healthcare, Scott held leadership positions at Oracle Health Sciences and IQVIA. He earned his Bachelor of Science from Clemson University and completed an Executive Leadership Program at the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill.
- Courtney McFall, UCSF
- Ben Rubin, UCSF
Patient-centric data – Real-World Evidence (RWE) and Real-World Data (RWD) - is becoming instrumental in the drug development process and for health care decisions in general. This data is not only informative for the process from discovery to new indications, clinical trial design, and drug development, it also can be of value to monitor post-marketing drug safety and for decision support in clinical practice. As the data becomes a decision driver, science companies and medical organizations are increasingly focused on leveraging RWD and RWE to not only better understand the patient populations using their drugs and the respective outcomes, but also to accelerate clinical decision support. This session will focus on the various aspects of integrating RWE and RWD to support drug development and clinical decision support.